Subscribe to RSS
DOI: 10.1055/s-0043-109483
Interventionelle Therapie des Schlaganfalls
Ein interdisziplinärer AnsatzInterventional therapy of stroke - an interdisciplinary conceptPublication History
Publication Date:
23 May 2017 (online)
![](https://www.thieme-connect.de/media/klinikarzt/201705/lookinside/thumbnails/246_10-1055-s-0043-109483-1.jpg)
Die mechanische Thrombektomie (MT) von Verschlüssen großer Hirngefäße in Kombination mit der systemischen intravenösen Thrombolyse (IVT) hat sich in den letzten Jahren zu einem hocheffektiven evidenzbasierten Verfahren der Akuttherapie des Hirninfarkts entwickelt. Die Chance auf ein behinderungsfreies Überleben der in der Regel schwer betroffenen Patienten wird um ca. 75% erhöht. Allerdings stellt die MT nur für maximal 1-5 % der Patienten mit ischämischem Schlaganfall eine Therapieoption dar. Die Akuttherapie der ischämischen Schlaganfälle fußt daher weiter hauptsächlich auf den etablierten Maßnahmen wie Stroke-Unit-Behandlung, frühe Sekundärprophylaxe und IVT. Die flächendeckende Versorgung der Kandidaten für eine MT stellt eine logistische Herausforderung dar, zu denen auch die Optimierung der interdisziplinären Zusammenarbeit gehört. Die MT hat auch Implikationen für die Akuttherapie oral antikoagulierter Schlaganfallpatienten. Eine moderne Schlaganfallbehandlung erfordert die interdisziplinäre Kooperation von Neurologie, Neuroradiologie, Neurochirurgie, Kardiologie, Gefäßchirurgie und Anästhesie.
Mechanical thrombectomy (MT) of occlusions of large cerebral arteries in combination with systemic intravenous thrombolysis (IVT) has developed during the last years as effective procedure for the acute treatment of ischemic stroke. The chance of a disability-free survival of patients who are usually severely affected is increased by approximately 75 %. However, MT is a therapeutic option for only a maximum of 1-5 % of patients with ischemic stroke. The acute treatment of ischemic stroke is therefore based on established strategies such as stroke-unit treatment, early secondary prophylaxis and IVT. The nationwide coverage of the candidates for an MT bears some logistical challenges, including the optimization of interdisciplinary cooperation. MT also has implications for the acute therapy of patients undergoing oral anticoagulation. Modern stroke treatment requires the interdisciplinary cooperation of neurology, neuroradiology, neurosurgery, cardiology, vascular surgery and anesthesia.
-
Literatur
- 1 Heuschmann PU, Busse O, Wagner M et al Schlaganfallhäufigkeit und Versorgung von Schlaganfallpatienten in Deutschland. Akt Neurol 2010; 37: 333-340
- 2 Rothwell PM, Coull AJ, Silver LE et al Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366: 1773-1783
- 3 Campbell BC, Christensen S, Levi CR et al Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke 2012; 43: 2648-2653
- 4 Anonymous Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587
- 5 Rothwell PM, Algra A, Chen Z et al Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 2016; 388: 365-375
- 6 Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2013. 9. CD000197
- 7 Emberson J, Lees KR, Lyden P et al Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials. Lancet 2014; 384: 1929-1935
- 8 Broderick JP, Palesch YY, Demchuk AM et al Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903
- 9 Ciccone A, Valvassori L, Nichelatti M et al Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 904-913
- 10 Kidwell CS, Jahan R, Gornbein J et al A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-923
- 11 Campbell BC, Mitchell PJ, Kleinig TJ et al Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009-1018
- 12 Goyal M, Demchuk AM, Menon BK et al Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019-1030
- 13 Berkhemer OA, Fransen PS, Beumer D et al A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015; 372: 11-20
- 14 Saver JL, Goyal M, Bonafe A et al Stent-retriever thrombectomy after intravenous tPA vs. tPA alone in stroke. N Engl J Med 2015; 372: 2285-2295
- 15 Jovin TG, Chamorro A, Cobo E et al Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296-2306
- 16 Goyal M, Menon BK, van Zwam WH et al Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723-1731
- 17 Saver JL, Goyal M, van der Lugt A et al Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 2016; 316: 1279-1288
- 18 Bracard S, Ducrocq X, Mas JL et al THRACE investigators. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol 2016; 15: 1138-1147
- 19 Mocco J, Zaidat OO, von Kummer R et al THERAPY Trial Investigators. Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone. Stroke 2016; 47: 2331-2338
- 20 Muir KW, Ford GA, Messow CM et al PISTE Investigators. Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial. J Neurol Neurosurg Psychiatry 2017; 88: 38-44
- 21 Barber PA, Demchuk AM, Zhang J et al Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670-1674
- 22 Brinjikji W, Murad MH, Rabinstein AA et al Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2015; 36: 525-529
- 23 Schönenberger S, Uhlmann L, Hacke W et al Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA 2016; 316: 1986-1996
- 24 Nallamothu BK, Bates ER, Herrin J et al Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005; 111: 761-767
- 25 Weber R, Reimann G, Weimar C et al Neurovascular Net Ruhr. Outcome and periprocedural time management in referred versus directly admitted stroke patients treated with thrombectomy. Ther Adv Neurol Disord 2016; 9: 79-84
- 26 Busse O, Röther J, Faiss J et al Interdisziplinäres neurovaskuläres Netzwerk. Eine neue Struktur zur Versorgung von Schlaganfällen und anderen Hirngefäßerkrankungen in Deutschland. Nervenarzt 2013; 84: 1228-1232
- 27 Diener HC, Foerch C, Riess H et al Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving antithrombotic treatment. Lancet Neurol 2013; 12: 677-688
- 28 Seiffge DJ, Hooff RJ, Nolte CH et al NOACISP Study Group. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome. Circulation 2015; 132: 1261-1269
- 29 Berrouschot J, Stoll A, Hogh T et al Intravenous thrombolysis with recombinant tissue-type plasminogen activator in a stroke patient receiving dabigatran anticoagulant after antagonization with idarucizumab. Stroke 2016; 47: 1936-1938
- 30 Purrucker JC, Steiner T. Management of acute stroke in patients on oral anticoagulants. Curr Opin Neurol 2017; 30: 1-7